Seguir
Oliver Schnell
Oliver Schnell
Dept. of Neurosurgery, Universitätsklinikum Erlangen
Dirección de correo verificada de uk-erlangen.de - Página principal
Título
Citado por
Citado por
Año
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
The lancet oncology 15 (10), 1100-1108, 2014
10192014
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ...
The Lancet Oncology 18 (10), 1373-1385, 2017
9492017
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
534*2021
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a …
U Herrlinger, T Tzaridis, F Mack, JP Steinbach, U Schlegel, M Sabel, ...
The lancet 393 (10172), 678-688, 2019
4732019
Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man
AJ Beer, R Haubner, M Sarbia, M Goebel, S Luderschmidt, AL Grosu, ...
Clinical Cancer Research 12 (13), 3942-3949, 2006
4392006
MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trial
M Weller, G Tabatabai, B Kästner, J Felsberg, JP Steinbach, A Wick, ...
Clinical cancer research 21 (9), 2057-2064, 2015
3642015
Mapping microglia states in the human brain through the integration of high-dimensional techniques
R Sankowski, C Böttcher, T Masuda, L Geirsdottir, Sagar, E Sindram, ...
Nature neuroscience 22 (12), 2098-2110, 2019
3402019
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
G Reifenberger, B Hentschel, J Felsberg, G Schackert, M Simon, ...
International journal of cancer 131 (6), 1342-1350, 2012
3092012
Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma
D Henrik Heiland, VM Ravi, SP Behringer, JH Frenking, J Wurm, ...
Nature communications 10 (1), 2541, 2019
2832019
A vaccine targeting mutant IDH1 in newly diagnosed glioma
M Platten, L Bunse, A Wick, T Bunse, L Le Cornet, I Harting, F Sahm, ...
Nature 592 (7854), 463-468, 2021
2792021
Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography
O Schnell, B Krebs, J Carlsen, I Miederer, C Goetz, RH Goldbrunner, ...
Neuro-oncology 11 (6), 861-870, 2009
2502009
Expression of Integrin αvβ3 in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature
O Schnell, B Krebs, E Wagner, A Romagna, AJ Beer, SJ Grau, N Thon, ...
Brain pathology 18 (3), 378-386, 2008
2202008
Molecular markers in low-grade gliomas: predictive or prognostic?
C Hartmann, B Hentschel, M Tatagiba, J Schramm, O Schnell, C Seidel, ...
Clinical Cancer Research 17 (13), 4588-4599, 2011
2192011
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
M Westphal, O Heese, JP Steinbach, O Schnell, G Schackert, M Mehdorn, ...
European journal of cancer 51 (4), 522-532, 2015
2122015
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The …
U Herrlinger, N Schäfer, JP Steinbach, A Weyerbrock, P Hau, ...
Journal of Clinical Oncology 34 (14), 1611-1619, 2016
1972016
Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)
C Schichor, T Birnbaum, N Etminan, O Schnell, S Grau, S Miebach, ...
Experimental neurology 199 (2), 301-310, 2006
1922006
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
VM Ravi, P Will, J Kueckelhaus, N Sun, K Joseph, H Salié, L Vollmer, ...
Cancer cell 40 (6), 639-655. e13, 2022
1882022
Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas
EM Grasbon‐Frodl, FW Kreth, M Ruiter, O Schnell, K Bise, J Felsberg, ...
International journal of cancer 121 (11), 2458-2464, 2007
1882007
Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM
B Suchorska, NL Jansen, J Linn, H Kretzschmar, H Janssen, S Eigenbrod, ...
Neurology 84 (7), 710-719, 2015
1842015
FET–PET for malignant glioma treatment planning
M Niyazi, J Geisler, A Siefert, SB Schwarz, U Ganswindt, S Garny, ...
Radiotherapy and Oncology 99 (1), 44-48, 2011
1642011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20